Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Correction

Published on 11 Sep 2023

Corrigendum: Systematic characterization of the clinical relevance of KPNA4 in pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jingpiao Bao
Chaoliang Xu
Bin Li
Zengkai Wu
Jie Shen
Pengli Song
Qi Peng
Guoyong Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1282120

986 views

Original Research

Published on 06 Sep 2023

Lipids, cholesterols, statins and liver cancer: a Mendelian randomization study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zicheng Liang
Zhen Zhang
Xiaoning Tan
Puhua Zeng

Frontiers in Oncology

doi 10.3389/fonc.2023.1251873

7,353 views
11 citations

Review

Published on 05 Sep 2023

Biliary drainage in malignant biliary obstruction: an umbrella review of randomized controlled trials

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yaoqun Wang
Ningyuan Wen
Xianze Xiong
Bei Li
Jiong Lu

Frontiers in Oncology

doi 10.3389/fonc.2023.1235490

3,767 views
2 citations

Original Research

Published on 01 Sep 2023

Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hee Seung Lee
Eun Hye Jung
Hyejung Shin
Chan Su Park
Soo Been Park
Dawoon E. Jung
Galam Leem
So Jung Kim
Jung Hyun Jo
Moon Jae Chung

Frontiers in Oncology

doi 10.3389/fonc.2023.1206565

1,931 views
3 citations

Correction

Published on 31 Aug 2023

Corrigendum: Machine learning prediction model for post- hepatectomy liver failure in hepatocellular carcinoma: a multicenter study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jitao Wang
Tianlei Zheng
Yong Liao
Shi Geng
Jinlong Li
Zhanguo Zhang
Dong Shang
Chengyu Liu
Peng Yu
Yifei Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1278295

1,566 views

Correction

Published on 31 Aug 2023

Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuting Dong
Xiaozhao Liu
Bijun Jiang
Siting Wei
Bangde Xiang
Ruichu Liao
Qiuyan Wang
Ximiao He

Frontiers in Oncology

doi 10.3389/fonc.2023.1253552

1,246 views

Perspective

Published on 30 Aug 2023

Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hossein Taghizadeh
Angela Djanani
Wolfgang Eisterer
Armin Gerger
Birgit Gruenberger
Thomas Gruenberger
Holger Rumpold
Lukas Weiss
Thomas Winder
Ewald Wöll

Frontiers in Oncology

doi 10.3389/fonc.2023.1225154

4,787 views
2 citations

Original Research

Published on 29 Aug 2023

Comparison between regular additional endobiliary radiofrequency ablation and photodynamic therapy in patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Christian Möhring
Oliver Khan
Taotao Zhou
Farsaneh Sadeghlar
Robert Mahn
Dominik J. Kaczmarek
Leona Dold
Marieta Toma
Milka Marinova
Tim R. Glowka

Frontiers in Oncology

doi 10.3389/fonc.2023.1227036

1,833 views
3 citations

Original Research

Published on 28 Aug 2023

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Sun
Yiqi Xiong
Qi Wang
Wenying Qiao
Honghai Zhang
Yonghong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1206345

1,606 views
7 citations

Original Research

Published on 28 Aug 2023

Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Amol Gupta
Ana De Jesus-Acosta
Lei Zheng
Valerie Lee
Ihab Kamel
Dung Le
Michael Pishvaian
Daniel Laheru

Frontiers in Oncology

doi 10.3389/fonc.2023.1250136

3,844 views
2 citations

Review

Published on 25 Aug 2023

Potential predictive role of gut microbiota to immunotherapy in HCC patients: a brief review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Paola Muscolino
Barbara Granata
Fausto Omero
Claudia De Pasquale
Stefania Campana
Alessia Calabrò
Federica D’Anna
Fabiana Drommi
Gaetana Pezzino
Riccardo Cavaliere

Frontiers in Oncology

doi 10.3389/fonc.2023.1247614

2,953 views
10 citations

Original Research

Published on 24 Aug 2023

Intratumoral and peritumoral radiomics model based on abdominal ultrasound for predicting Ki-67 expression in patients with hepatocellular cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hongwei Qian
Zhihong Shen
Difan Zhou
Yanhua Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1209111

2,505 views
11 citations

Original Research

Published on 23 Aug 2023

Low host immune pressure may be associated with the development of hepatocellular carcinoma: a longitudinal analysis of complete genomes of the HBV 1762T, 1764A mutant

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Zhi-Hua Jiang
Qin-Yan Chen
Hui-Hua Jia
Xue-Yan Wang
Lu-Juan Zhang
Xiao-Qian Huang
Tim J. Harrison
J. Brooks Jackson
Li Wu
Zhong-Liao Fang

Frontiers in Oncology

doi 10.3389/fonc.2023.1214423

1,360 views

Original Research

Published on 22 Aug 2023

Fibrosis-4 index is associated with the risk of hepatocellular carcinoma in patients with cirrhosis and nonalcoholic steatohepatitis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Somaya Albhaisi
Jing Sun
Arun J. Sanyal

Frontiers in Oncology

doi 10.3389/fonc.2023.1198871

2,214 views
3 citations

Case Report

Published on 22 Aug 2023

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Senmiao Huang
Dianhe Li
Yongye Huang
Guojie Lu
Ying Tian
Xuefeng Zhong
Yating Zheng
Mengli Huang
Fuxi Huang

Frontiers in Oncology

doi 10.3389/fonc.2023.1191646

1,717 views

Original Research

Published on 18 Aug 2023

Comparison analysis of PD-1/PD-L1 inhibitors plus lenvatinib or gemcitabine/cisplatin as first-line treatment for patients with advanced intrahepatic cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jia-Xin Huang
Bo Liu
Yu Li
Xi Li
Li-Juan Ding
Nan-Ya Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1204486

1,980 views
4 citations